regulatory
confidence high
sentiment negative
materiality 0.70
Insulet voluntary correction for ~7M Omnipod Pods due to cannula tear, up to $50M cost
INSULET CORP
- ~7M Pods affected (60% consumed/expired); 24 serious adverse events (hospitalization/DKA), no deaths.
- Up to $50M cost in 2026 excluded from adjusted results; no change to 2026 guidance.
- Separate from March 2026 correction; cause identified and corrective actions implemented.
- No expected disruption to shipments, product availability, or new customer starts.